reports
- Alvaro del Pozo
- Emmanuel Matot
- Marc Lavaud
- Marc Lavaud
- Robert Jan Vos
- Emmanuel Matot
- Marc Lavaud
- Marc Lavaud
- Robert Jan Vos
- Alvaro del Pozo
ASML HOLDING NV: RDOS. 3T’24 (ANÁLISIS BANCO SABADELL)
Rdos. 3T'24 vs 3T'23: Ventas: 7.467 M euros (+11,9% vs +6,4% BS(e) y +7,7% consenso); EBIT: 2.441 M euros (+11,9% vs +0,4% BS(e) y +2,5% consenso); BDI: 2.077 M euros (+9,7% vs -0,2% BS(e) y +0,8% consenso). Rdos. 9meses'24 vs 9meses'23: Ventas: 19.000 M euros (-6,5% vs -8,3% BS(e) y -7,9% consenso); EBIT: 5.667 M euros (-14,8% vs -18,5% BS(e) y -17,9% consenso); BDI: 4.878 M euros (-15,8% vs -19,0% BS(e) y -18,7% consenso).
- Andreas Riemann
- Wim Gille
JUST EAT TAKEWAY.COM : Another boring quarter
>Boring 3Q24 set of results. - TKWY results were a marginal miss vs company compiled consensus. Group orders (both in and excluding North America) are down 3% year-on-year, missing consensus by 1%. Group GTV is down 2% year-on-year missing consensus by 2%. Excluding North America Group GTV is up 3% year-on-year. Deviations are same same across the regions. Outlook reiterated - Company cites an improved exit rate following a slower July. In addition th...
- Martin Marandon-Carlhian
- Stephane Houri
ASML : Major misstep, disappointing orders and downgrade for 2025, but...
>Unpleasant surprise, but impact more under control than feared, 2025-2026 outlook cut by 10% and target lowered to € 950, Outperform rating maintained - ASML yesterday mistakenly issued its Q3 2024 results release during trading. It contained good Q3 results and satisfactory Q4 guidance, but also very disappointing orders (even relative to our forecast which was actually lower than the consensus) and a downgrade to its 2025 guidance to the lower end of the range (€ 3...
- ING Helpdesk
Benelux Morning Notes
ABN AMRO: NLFI selling down to 30% stake, outlook for below 15%. ASML: 3Q24 results – ouch, that hurts. Gimv: Linking Belgian brewery craftmanship with Dutch commercial spirit. Just Eat Takeaway.com: No order growth yet. PostNL: New CLAs for PostNL employees and for Saturday deliverers
- Jan Frederik Slijkerman
- Jeroen van den Broek
- Jesse Norcross
- Nadège Tillier
- Timothy Rahill
- Michiel Declercq
- Thibault Leneeuw
- Thomas Couvreur
- Thibault Leneeuw
ASML Impact of the adjusted 2025 guidance
In this note we adjust our numbers based on the reduced outlook. Our first indication shows that EPS forecasts for 2025 and beyond will come down with c. 20%. Furthermore, even larger adjustments in 2026 and 2027 are likely based on CSS CapEx estimates of Semi manufacturers. This while Chinese demand will normalize. Our adjustments result in a TP of € 760 per share and we reiterate our Accumulate rating.
- Thomas Couvreur
Randstad Adjusting model for a more subdued market
We have updated our estimates following a significant weaker macro environment than we had anticipated last quarter. While we were banking on a recovery of confidence, fuelled by lower interest rates, we have seen many indicators for the quarter take a significant hit. Adjusting our FY24-FY25 estimates, we come to a new DCF valuation of €47.5, down from €52 previously. We reiterate our Accumulate rating.
- Martin Marandon-Carlhian
- Stephane Houri
ASML : Une grosse maladresse, des commandes décevantes et une révision...
>Une mauvaise surprise, mais un impact plus contenu que craint, prévisions 25/26 abaissées de 10% et notre OC à 950 €, nous restons à Surperformance - Hier, ASML a publié par erreur son communiqué de résultat T3 24 en pleine séance. Il contenait de bons résultats pour le T3 et une guidance T4 satisfaisante, mais aussi des commandes très décevantes (même par rapport à notre prévision qui était pourtant inférieure au consensus) et une révision en baisse de la guidance 2...
- Research Department
INFORME DIARIO 16 0CTUBRE + RDOS. ESPAÑA Y EUROPA 3T’24. PREVIEWS (ANÁ...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: OHLA, SECTOR BANCOS, SECTOR ENERGÍA, TALGO. EUROPA: ADIDAS, ASML, LVMH, SECTOR BANCOS ITALIA. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. El Ibex sigue liderando Europa y se desmarca de las caídas del Euro STOXX Jornada de más a menos en Eu...
- Pierre FerraguÊ
STATEMENT RELATING TO EARLY PUBLICATION OF OUR Q3 2024 RESULTS
STATEMENT RELATING TO EARLY PUBLICATION OF OUR Q3 2024 RESULTS STATEMENT RELATING TO EARLY PUBLICATION OF OUR Q3 2024 RESULTS Due to a technical error, information relating to our Q3 2024 results was erroneously published earlier today on part of our website asml.com. For transparency, ASML brought forward publication of its full Q3 2024 results to October 15th. All Q3 2024 content is available on our website at
- Alvaro del Pozo
ASML reports €7.5 billion total net sales and €2.1 billion net income ...
ASML reports €7.5 billion total net sales and €2.1 billion net income in Q3 2024 ASML reports €7.5 billion total net sales and €2.1 billion net income in Q3 2024 ASML expects total net sales for 2024 of around €28 billion VELDHOVEN, the Netherlands, October 15, 2024 – Today, ASML Holding NV (ASML) has published its 2024 third-quarter results. Q3 total net sales of €7.5 billion, gross margin of 50.8%, net income of €2.1 billionQuarterly net bookings in Q3 of €2.6 billion2 of which €1.4 billion is EUVASML expects Q4 2024 total net sales between €8.8 billion a...
- Bruno Cavalier
- Jean Danjou
- Thomas Zlowodzki
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/14/2024
We are removing GSK from our European Large Caps Convictions List. The company is the only one of the six Big Pharma groups to have experienced a break in trend, which could act as a drag on future publications. Our analyst adjusted this morning his EPS estimates for 2024/2025/2026 by -0.6%, 2.0% and- 3.4% respectively, factoring in weaker growth for Arexvy and Shingrix, hence the lowering of his target price from 2,150p to 1,900p. - ...
CA CARREFOUR SA
MC LVMH MOET HENNESSY LOUIS VUITTON SE
ROG ROCHE HOLDING LTD
ORA ORANGE SA
NOVN NOVARTIS AG
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SAND SANDVIK AB
EN BOUYGUES SA
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
SAN SANOFI
HEI HEIDELBERGCEMENT AG
AIR AIRBUS SE
01913 PRADA S.P.A.
MOCORP METSO OUTOTEC OYJ
FDR FLUIDRA S.A.
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
AZN ASTRAZENECA PLC
ASML ASML HOLDING NV
EPI A EPIROC AB
GSK GSK PLC
NOVO B NOVO NORDISK A/S
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.